Notal Vision

Notal VisionNotal Vision
Notal Vision

Notal Vision

Remote monitoring services for retinal diseases, extending care from clinic to home.

DR 322000Active80Tel Aviv, Israel
Rate

About

Notal Vision is a digital health company extending eye disease management from the clinic to the home with patient-operated diagnostic devices and AI-enabled data analysis. Their services, including ForeseeHome® and SCANLY® Home OCT, aim to help doctors diagnose wet AMD earlier and provide actionable insights for better patient outcomes. They serve ophthalmologists and their patients by enabling precision medicine in eye care through continuous monitoring and data analysis.
Frequently asked

What does Notal Vision do?

Notal Vision is a digital health company extending eye disease management from the clinic to the home with patient-operated diagnostic devices and AI-enabled data analysis. Their services, including ForeseeHome® and SCANLY® Home OCT, aim to help doctors diagnose wet AMD earlier and provide actionable insights for better patient outcomes. They serve ophthalmologists and their patients by enabling precision medicine in eye care through continuous monitoring and data analysis.

What is Notal Vision's valuation?

StartupHub estimates Notal Vision's effective valuation at $120.5M (range $84.4M to $156.7M, 25% confidence), based on comparable companies in the sector.

How much funding has Notal Vision raised?

Notal Vision has raised a total of $89M in funding. The most recent round on record is Series D.

Where is Notal Vision headquartered?

Notal Vision is headquartered in Tel Aviv, Israel.

When was Notal Vision founded?

Notal Vision was founded in 2000.

What industry does Notal Vision operate in?

Notal Vision operates in Ophthalmology, Age Related Macular Degeneration (AMD), Diagnostics, HealthTech, MedTech, Telemedicine.

How many employees does Notal Vision have?

Notal Vision has approximately 80 people on record.

HEADCOUNT
80
DOMAIN RATING
32
Comments

No comments yet. Be the first to share your take.